Supplementary Appendix: Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/nmhhzwb96h
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Appendix to: King B, et al. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1). J Am Acad Dermatol 2024
